Patent · US Active

Method for treating breast cancer using antibody binding to MMP-14

US9051377B2 · kind B2 · utility

1Cited by
12References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2011
Grant dateJun 9, 2015
Priority date—
Expiry dateDec 3, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/96486
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Proteins that bind to matrix metalloproteinase 14 and methods of using such proteins are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.